Impact of the Cycle Ergometer in Muscle Strength and Pulmonary Function in Patients in Hemodialysis

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02834026

Enrollment

Registered

2016-07-15

Start date

2016-01-31

Completion date

2018-01-30

Last updated

2019-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Renal Disease, Renal Dialysis

Keywords

Muscle Strength, Muscle Strength Dynamometer, Chronic Renal Disease, Exercise, Physical therapy modalities

Brief summary

Muscle strength can be measured by dynamometry, but the investigators did not find in the literature the study of this technique in the quadriceps of patients with chronic kidney disease on hemodialysis. Analyze training impact conducted by cycle ergometer in quadriceps muscle strength in patients with chronic kidney disease during hemodialysis. This study will be a prospective, randomized. Inclusion of 46 patients followed by the dialysis unit of a university hospital, over 18 years, of both genders who underwent hemodialysis for more than six months and signed the consent form and enlightened. Patients will be divided into two groups: Intervention (n = 23) and control (n = 23). All will be evaluated for demographics and quadriceps strength given by standardization of technique, with hard and windy belt. The control group will be reassessed after two months of the initial assessment, since the intervention group held two months of training in hemodialysis a physical therapy protocol with the cycle ergometer.

Interventions

OTHERCicloergometry training

OTHERNo Cicloergometry training

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 100 Years

Healthy volunteers

Yes

Inclusion criteria

* Patients aged over 18 years * Performing HD over six months * Clinically stable * Patients no diagnosis of lung disease * Neurological or mioarticular previous or current and agreed to participate in the study and signed informed consent and informed

Exclusion criteria

* Patients undergoing elective surgery or emergency six months before or during the performance of the protocol * Cardiac decompensation * Used continuous or nocturnal oxygen * Patients using bracing of the lower limbs.

Design outcomes

Primary

Measure	Time frame	Description
Muscle strength evaluated by dynamometry	Two months	dynamometry
Peripheral blood tests	Two months	hemoglobin (g / dL)

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026